Lignin in Treatment of Helicobacter Pylori Infection

Condition(s) studied

Investigational drug(s) / intervention(s)

Hydrolyzed Lignin: The drug will be supplied randomly to the group I

Placebo: Will be supplied randomly to Group II

Study summary

The goal of this clinical trial is to learn if drug hydrolyzed lignin works to treat H pylori infection in adults. It will also learn about the safety of drug lignin n the sitting of H pylori infection, and if it halts the side effects associated with H pylori triple therapy. The main questions it aims to answer are:

* Does drug hydrolyzed lignin improve the H pylori eradiation rate when it is added to the standard triple therapy used in treatment of H pylori?
* What medical problems do participants experience when taking drug hydrolyzed lignin? Researchers will compare drug hydrolyzed lignin to a placebo (a look-alike substance that contains no drug) to see if drug hydrolyzed lignin works to treat H pylori.

Participants will:

* Take drug hydrolyzed lignin or a placebo every day for 2 weeks beside the standard triple therapy
* Visit the clinic once every 1 week for checkup and questionnaire filling
* Check for H pylori eradication after treatment

Eligibility

Primary outcome measure(s)

• Eradication rate — 2 weeks of continuous treatment, followed by 2 weeks of treatment and then testing again for presence\absence of the infection
  How much the H pylori eradication rate following the treatment

Trial sites (1)

More Zagazig University trials in Egypt

Other trials for the same condition